Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Change in Cash (2016 - 2025)

Macrogenics (MGNX) has disclosed Change in Cash for 14 consecutive years, with -$22.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Cash fell 812.66% to -$22.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$125.6 million, a 253.42% decrease, with the full-year FY2025 number at -$125.6 million, down 253.42% from a year prior.
  • Change in Cash was -$22.9 million for Q4 2025 at Macrogenics, up from -$50.6 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $115.4 million in Q1 2023 to a low of -$115.5 million in Q2 2023.
  • A 5-year average of -$6.2 million and a median of -$16.9 million in 2023 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: surged 3905.38% in 2022, then crashed 812.66% in 2025.
  • Macrogenics' Change in Cash stood at -$67.1 million in 2021, then skyrocketed by 137.12% to $24.9 million in 2022, then plummeted by 55.57% to $11.1 million in 2023, then plummeted by 70.93% to $3.2 million in 2024, then plummeted by 812.66% to -$22.9 million in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Change in Cash are -$22.9 million (Q4 2025), -$50.6 million (Q3 2025), and -$14.9 million (Q2 2025).